Safety of beta‐nicotinamide mononucleotide (β‐NMN) pursuant the regulation (EU) 2015/2283 and the bioavailability of nicotinamide from this source in the context of Directive 2002/46/EC
Following a request from the European Commission, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on beta‐nicotinamide mononucleotide (β‐NMN) as a...
Want the full context? Use Regulator to track the source, deadlines, and weekly briefing.Document type: News/Update. Agency: International - EFSA. Published: 2026-05-12.
Why this matters to food and beverage teams
This news update is worth screening if your team tracks international - efsa activity that could affect ingredients, labeling, plant operations, imports, or compliance timing.
The practical question is whether this changes food safety and label-control exposure. If it does, pull the source document and decide whether the item needs action now, monitoring, or no response.
Need the operator impact, not just the source document?
Get a custom Regulator Weekly Action Brief with the deadlines, business impact, and next actions that matter to your facility or product line. Your first custom brief is free.